Skip to main content
Premium Trial:

Request an Annual Quote

Cytomyx Buys Tissue Bank Business from Ardais for $3M

NEW YORK, March 30 (GenomeWeb News) - Cytomyx has bought the tissue bank business from Ardais for $3 million in cash, the Cambridge, UK-based company said today.

 

Cytomyx purchased the newly formed subsidiary of Lexington, Mass.-based Ardais, called Biorepository Business. The subsidiary includes a tissue bank of more than 130,000 human tissue samples with clinical information, primarily from cancer patients. The business also offers tissue microarray and other molecular products as well as immunohistochemistry services. Last year, the business unit had $3.7 million in revenues.

 

Following the acquisition, Cytomyx will relocate its current USbiorepository facility and key personnel from Albany, New York, to Ardais' Lexingtonfacility. Cytomyx will also gain access to Ardais' web-searchable biospecimen management system.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.